112 related articles for article (PubMed ID: 2718234)
21. HLA antigens on platelet membranes. In vitro and in vivo studies.
Santoso S; Mueller-Eckhardt G; Santoso S; Kiefel V; Mueller-Eckhardt C
Vox Sang; 1986; 51(4):327-33. PubMed ID: 3798868
[TBL] [Abstract][Full Text] [Related]
22. Suitability of liquid-stored donor platelets in platelet compatibility testing.
Kiss JE; Salamon DJ; Wilson J; Ramsey G; Duquesnoy RJ
Transfusion; 1989 Jun; 29(5):405-10. PubMed ID: 2660335
[TBL] [Abstract][Full Text] [Related]
23. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
Freedman J; Gafni A; Garvey MB; Blanchette V
Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
[TBL] [Abstract][Full Text] [Related]
24. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
25. Labile coagulation factor activity in pooled random donor platelet concentrates.
Domen RE
South Med J; 1988 Mar; 81(3):418. PubMed ID: 3126552
[No Abstract] [Full Text] [Related]
26. HLA class I-eluted platelets as an alternative to HLA-matched platelets.
Novotny VM; Huizinga TW; van Doorn R; Briët E; Brand A
Transfusion; 1996 May; 36(5):438-44. PubMed ID: 8693509
[TBL] [Abstract][Full Text] [Related]
27. Platelet transfusion reaction associated with interdonor HLA incompatibility.
Eastlund DT; McGrath PC; Burkart P
Vox Sang; 1988; 55(3):157-60. PubMed ID: 3266389
[TBL] [Abstract][Full Text] [Related]
28. Single-donor platelet concentrates stored in synthetic medium. In vitro and in vivo studies.
Bertolini F; Marangoni F; Loy A; Marconi M; Almini D; Rebulla P; Sirchia G
Int J Artif Organs; 1993 Dec; 16 Suppl 5():135-8. PubMed ID: 8013972
[TBL] [Abstract][Full Text] [Related]
29. An enzyme-linked immunosorbent assay for platelet compatibility testing.
Tamerius JD; Curd JG; Tani P; McMillan R
Blood; 1983 Oct; 62(4):744-9. PubMed ID: 6882922
[TBL] [Abstract][Full Text] [Related]
30. Four crossmatch methods to select platelet donors.
Kakaiya RM; Gudino MD; Miller WV; Sherman LA; Katz AJ; Wakem CJ; Krugman DJ; Klatsky AU; Kiraly TR
Transfusion; 1984; 24(1):35-41. PubMed ID: 6364475
[TBL] [Abstract][Full Text] [Related]
31. Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22 degrees C. Importance of storage time.
Lazarus HM; Herzig RH; Warm SE; Fishman DJ
Transfusion; 1982; 22(1):39-43. PubMed ID: 7064205
[TBL] [Abstract][Full Text] [Related]
32. Platelet transfusion from donors mismatched for crossreactive HLA antigens.
Dahlke MB; Weiss KL
Transfusion; 1984; 24(4):299-302. PubMed ID: 6464151
[TBL] [Abstract][Full Text] [Related]
33. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
34. Platelet donor selection for HLA-immunised patients; the impact of donor-specific HLA antibody levels.
Linjama T; Niittyvuopio R; Tuimala J; Pyörälä M; Rintala H; Rimpiläinen J; Kauppila M; Peräsaari J; Juvonen E
Transfus Med; 2017 Oct; 27 Suppl 5():375-383. PubMed ID: 28382715
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
McFarland JG; Anderson AJ; Slichter SJ
Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125
[TBL] [Abstract][Full Text] [Related]
36. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
[TBL] [Abstract][Full Text] [Related]
37. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duqesnoy RJ
Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
[No Abstract] [Full Text] [Related]
38. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
Wu KK; Hoak JC; Koepke JA; Thompson JS
Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
[TBL] [Abstract][Full Text] [Related]
39. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
Benson K; Marks AR; Marshall MJ; Goldstein JD
Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
[TBL] [Abstract][Full Text] [Related]
40. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
